Potential Applications
| Sources of stem cells | Umbilical cord | |
| Types of stem cells | Cordlife's Exclusive : Epithelial stem cells (EpSCs) |
Mesenchymal stem cells (MSCs) |
|
Treatment |
Potential Wound / Soft Tissue Repair
Organ Regeneration
Eye
|
Potential Tissue Repair
Haematopoietic engraftment support Shorten time of engraftment : increase success rate of transplant Immune Modulation
|
Today, more than 170 clinical trials1 are ongoing worldwide to uncover the potential of MSCs. Thus far, encouraging results have been published; stem cell treatments have been proven safe and capable of repairing damage caused by stroke and heart disease. MSCs have also been used in combination with HSCs as a dual therapy to promote faster engraftment of HSCs and to reduce immune system complications2.
1 ClinicalTrials.gov. Accessed on 29 June 2011.
(http://www.clinicaltrials.gov/ct2/results?term=mesenchymal+stem+cells)
2 Battiwalla M, Hematti P. 2010. Cytotherapy. 1 January 2010.
Worldwide researches on diseases treated with MSCs by various universities or institutions:
| Diseases | Name of universities or research Institions |
| Stroke | University Hospital, Grenobe, France |
| Spinal Cord Injury |
|
| Multiple Sclerosis |
|
| Amylotrophic Lateral Sclerosis |
Hadassah Medical Organization, Israel |
| Parkinson's Disease |
Jaslok Hospital and Research Centre, India |
| Multiple System Atrophy |
Yonsei University, South Korea |
| Liver Disease |
Cytori Therapeutics, U.S. |
| Diabetic Foot Ulcer |
|
| Diabetes |
|
QR 8.1-7-3-a DCR 800

